张爽, 张辉, 沈成凤, 王冲, 孙坤, 王卓, 宋桂德, 王德征, 江国虹. 2008-2018年天津市慢病示范区期望寿命与主要慢病死亡水平分析[J]. 疾病监测, 2020, 35(6): 495-502. DOI: 10.3784/j.issn.1003-9961.2020.06.009
引用本文: 张爽, 张辉, 沈成凤, 王冲, 孙坤, 王卓, 宋桂德, 王德征, 江国虹. 2008-2018年天津市慢病示范区期望寿命与主要慢病死亡水平分析[J]. 疾病监测, 2020, 35(6): 495-502. DOI: 10.3784/j.issn.1003-9961.2020.06.009
Shuang Zhang, Hui Zhang, Chengfeng Shen, Chong Wang, Kun Sun, Zhuo Wang, Guide Song, Dezheng Wang, Guohong Jiang. Life expectancy and mortality rates of major chronic disease in demonstration area of Tianjin, 2008–2018[J]. Disease Surveillance, 2020, 35(6): 495-502. DOI: 10.3784/j.issn.1003-9961.2020.06.009
Citation: Shuang Zhang, Hui Zhang, Chengfeng Shen, Chong Wang, Kun Sun, Zhuo Wang, Guide Song, Dezheng Wang, Guohong Jiang. Life expectancy and mortality rates of major chronic disease in demonstration area of Tianjin, 2008–2018[J]. Disease Surveillance, 2020, 35(6): 495-502. DOI: 10.3784/j.issn.1003-9961.2020.06.009

2008-2018年天津市慢病示范区期望寿命与主要慢病死亡水平分析

Life expectancy and mortality rates of major chronic disease in demonstration area of Tianjin, 2008–2018

  • 摘要:
    目的分析2008 — 2018年天津市慢病示范区期望寿命与主要慢性病死亡水平,评估慢病示范区的创建成效。
    方法采用2008 — 2018年天津市疾病预防控制中心收集的天津市全人口全死因监测数据,对比示范区、非示范区和全市居民在期望寿命、全死因和主要慢性病(心脑血管疾病、恶性肿瘤、糖尿病和慢性下呼吸道疾病)死亡水平的差异。 户籍人口数据来源于天津市公安局。 分析指标包括粗死亡率、标化死亡率和期望寿命、年度变化百分比(APC),并进行统计学检验。
    结果2008 — 2018年,天津市慢病示范区户籍居民的期望寿命每年均高于同期非示范区,示范区居民的期望寿命由2008年的81.48岁上升至2018年的82.38岁(APC=0.19, P<0.05)。 示范区居民的全死因粗死亡率无变化趋势,同期非示范区和全市均呈上升趋势。 经标准人口构成调整后,示范区、非示范区及全市居民的全死因标化死亡率均无变化趋势。 示范区急性心肌梗死、慢性下呼吸道疾病和肝癌的粗死亡率和标化死亡率呈下降趋势,下降幅度大于非示范区;示范区女性乳腺癌、男性糖尿病死亡水平的上升幅度小于非示范区和全市;示范区大肠癌死亡水平的上升幅度大于非示范区和全市。
    结论天津市慢病示范区的建设已经初显成效,各示范区不断探索慢病防控新模式,为全市积累有益经验,整体带动全市慢病防治管理水平的提升。

     

    Abstract:
    ObjectiveTo analyze the life expectancy and mortality rates of major chronic diseases in demonstration area of Tianjin from 2008 to 2018, and evaluate the effects of the establishment of demonstration area for chronic disease prevention and control.
    MethodsBased on the data of all-cause deaths of the whole population in Tianjin, we compared the life expectancy and mortality rates of all-cause deaths and major chronic diseases (cardio-cerebrovascular diseases, malignant tumors, diabetes and chronic lower respiratory tract diseases) in residents in demonstration area, non-demonstration area and whole city of Tianjin. The population data were from Tianjin Municipal Public Security Bureau. The crude mortality rates, standardized mortality rate, life expectancy and annual percentage change were analyzed.
    ResultsThe people’s life expectancy increased from 81.48 years in 2008 to 82.38 years in 2018 in demonstration area (APC=0.19, P<0.05), and the annual people’s life expectancy was all higher in demonstration area than in non-demonstration area. The crude mortality rates of all-cause deaths showed no change trend in demonstration area, but showed upward trends in both non-demonstration area and whole city. The standardized mortality rates of all-cause deaths showed no change trend in demonstration area, non-demonstration area and whole city after adjustment for standardized population constituent. The crude and standardized mortality rates of acute myocardial infarction, chronic lower respiratory diseases and liver cancer showed more decreases in demonstration area compared with non-demonstration area. The mortality rates of breast cancer in females and diabetes in males showed less increases in demonstration area than in non-demonstration area and whole city. The mortality rate of colorectal cancer showed more increase in demonstration area than in non-demonstration area and whole city.
    ConclusionThe establishment of chronic disease prevention and control demonstration area in Tianjin had shown effects. Each demonstration area explored their new models constantly for the prevention and control of chronic diseases, which would benefit the improvement of the prevention, control and management of chronic diseases in Tianjin.

     

/

返回文章
返回